Table 5.
Antimicrobial susceptibility results for Salmonella isolates from poultry.
| Antimicrobial class | Antimicrobials | # of isolates | Susceptibility profile | ||
|---|---|---|---|---|---|
| S (%) | I (%) | R (%) | |||
| Aminoglycosides | AMK | 210 | 210 (100%) | 0 | 0 |
| GEN | 210 | 210 (100%) | 0 | 0 | |
| Carbapenems | MER | 210 | 210 (100%) | 0 | 0 |
| IMP | 210 | 210 (100%) | 0 | 0 | |
| Cephalosporins | FOX (II) | 210 | 55 (26.2%) | 151 (71.9%) | 4 (1.9%) |
| CXM (II) | 210 | 52 (24.8%) | 63 (30%) | 95 (45.2%) | |
| CTX (III) | 210 | 210 (100%) | 0 | 0 | |
| CFZ (III) | 210 | 210 (100%) | 0 | 0 | |
| FEP (IV) | 210 | 210 (100%) | 0 | 0 | |
| Macrolides | AZM | 210 | 187 (89%) | 0 (0%) | 23 (11%) |
| Nitrofurans | NIT | 210 | 170 (81%) | 39 (18.6%) | 1 (0.4%) |
| Penicillins | AMX | 210 | 207 (98.6%) | 3 (1.4%) | 0 |
| AMP | 210 | 210 (100%) | 0 | 0 | |
| Phenicols | CHL | 210 | 167 (79.5%) | 39 (18.6%) | 4 (1.9%) |
| Quinolones | NA | 210 | 200 (95.2%) | 10 (4.8%) | 0 |
| PEF | 210 | 186 (88.6%) | 0 (0%) | 24 (11.4%) | |
| CIP | 210 | 210 (100%) | 0 | 0 | |
| Tetracyclines | TET | 210 | 210 (100%) | 0 | 0 |
| TGC | 210 | 210 (100%) | 0 | 0 | |
| Other | AMC | 210 | 210 (100%) | 0 | 0 |
| SXT | 210 | 210 (100%) | 0 | 0 | |
S: susceptible; I: intermediate; R: resistant; AMC: amoxicillin/clavulanic acid; AMK: amikacin; AMP: ampicillin; AZM: azithromycin; CIP: ciprofloxacin; CXM: cefuroxime; FOX: cefoxitin; CHL: chloramphenicol; CTX: cefotaxime; CFZ: ceftazidime; FEP: cefepime; GEN: gentamicin; IMP: imipenem; MER: meropenem; NIT: nitrofurantoin; PEF: pefloxacin; TET: tetracycline; TGC: tigecycline; SXT: trimethoprim/sulfamethoxazole.